Eisai Plans Entry Into Nucleic Acid Drug Market Apr. 2, 2018 Eisai Co. Ltd. (TYO:4523) is gearing up to make a full-fledged entry into the nucleic acid drug market. Leveraging tie-ups…... Please subscribe to read the full story. Subscribe Free Trial